Seeing Is Believing

Currently out of the existing stock ratings of Steve Byrne, 28 are a SELL (16.67%), 90 are a BUY (53.57%), 50 are a HOLD (29.76%).
Analyst Steve Byrne, currently employed at BAML, carries an average stock price target met ratio of 56.32% that have a potential upside of 25.71% achieved within 242 days.
Steve Byrne’s has documented 649 price targets and ratings displayed on 36 stocks. The coverage is on Basic Materials, Consumer Defensive, Healthcare sectors.
Most recent stock forecast was given on ALB, Albemarle Corp at 13-Oct-2025.
Analyst best performing recommendations are on INVA (INNOVIVA).
The best stock recommendation documented was for INVA (INNOVIVA) at 2/19/2015. The price target of $17 was fulfilled within 1 day with a profit of $0.68 (4.17%) receiving and performance score of 41.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$90
$-15.64 (-14.80%)
$75
14 days ago
(14-Oct-2025)
14/22 (63.64%)
$-8.16 (-8.31%)
203
Buy
$100
$-5.64 (-5.34%)
$126
15 days ago
(13-Oct-2025)
7/13 (53.85%)
$3.76 (3.91%)
24
Buy
$100
$-5.64 (-5.34%)
$156
15 days ago
(13-Oct-2025)
4/5 (80%)
$3.76 (3.91%)
527
Hold
$92
$-13.64 (-12.91%)
$85
26 days ago
(02-Oct-2025)
26/29 (89.66%)
$3.78 (4.28%)
149
Sell
$68
$-37.64 (-35.63%)
$60
2 months ago
(28-Aug-2025)
21/27 (77.78%)
$-16.46 (-19.49%)
328
Which stock is Steve Byrne is most bullish on?
Which stock is Steve Byrne is most reserved on?
What Year was the first public recommendation made by Steve Byrne?